Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
8 studies found for:    Open Studies | "Chagas Disease"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Chagas Disease"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Prospective Study of a Pediatric Nifurtimox Formulation for Chagas' Disease
Condition: Chagas Disease
Interventions: Drug: Nifurtimox (BAYA2502);   Drug: Nifurtimox (BAYA2502) followed by Placebo
2 Recruiting Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS)
Condition: Chagas Disease With Heart Failure
Intervention: Drug: Aspirin
3 Recruiting Selenium Treatment and Chagasic Cardiopathy (STCC)
Condition: Chagas Disease
Interventions: Drug: Selenium;   Drug: Placebo (for Selenium)
4 Recruiting CHICAMOCHA 3 - Equivalence of Usual Interventions for Trypanosomiasis (EQUITY)
Condition: Chagas Disease
Interventions: Drug: Nifurtimox;   Drug: Benznidazole;   Drug: Placebo
5 Recruiting Study to Evaluate Fexinidazole Dosing Regimens for the Treatment of Adult Patients With Chagas Disease
Conditions: Chagas Disease;   Trypanosomiasis, South American;   South American Trypanosomiasis;   Disease, Chagas
Interventions: Drug: Fexinidazole;   Drug: Placebo
6 Recruiting Impact of the Pharmaceutical Care on the Quality of Life in Patients With Chagas Heart Disease
Condition: Chagas Heart Disease
Interventions: Other: Standard care and Pharmaceutical care;   Other: Standard care
7 Recruiting Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection
Condition: Parasitic Disease
Intervention:
8 Not yet recruiting Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention of Death
Conditions: Chagas Cardiomyopathy;   Non-sustained Ventricular Tachycardia;   At Least 10 Points in Rassi Risk Score for Death
Interventions: Procedure: ICD implantation;   Drug: amiodarone hydrochloride

Study has passed its completion date and status has not been verified in more than two years.